- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.090
2.140
52 wk Range
1.600
4.670
Microbot Medical Inc Company Profile
Get an in-depth profile of Microbot Medical Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body’s vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Contact Information
Address
175 Derby Street Bld. 27, Hingham, 02043, United States
Phone
781 875 3605
Website
Top Executives
Name | Title | Since | Age |
|---|---|---|---|
| Harel Gadot | Co-Founder, President, CEO & Chairman | 2016 | 53 |
| Scott R. Burell | Independent Director | 2016 | 61 |
| Martin J. Madden | Independent Director | 2017 | 65 |
| Prattipati Laxminarain | Independent Director | 2017 | 68 |
| Eyal Morag | Member of Scientific Advisory Board | 2020 | 61 |
| Aileen Ptucha Stockburger | Independent Director | 2020 | 63 |
| Tal Baruch Wenderow | Independent Director | 2020 | 51 |
| Giora Weisz | Member of Scientific Advisory Board | 2022 | - |
| Ajay K. Wakhloo | Member of Scientific Advisory Board | 2022 | - |
| Stephen B. Solomon | Member of Scientific Advisory Board | 2022 | - |
| Dmitry J. Rabkin | Member of Scientific Advisory Board | 2022 | - |
| Gal Yaniv | Member of Scientific Advisory Board | 2022 | - |
| Ziv Neeman | Member of Scientific Advisory Board | 2022 | - |
| Sebastian Flacke | Member of Scientific Advisory Board | 2022 | - |
| Vincent Vidal | Member of Scientific Advisory Board | 2022 | - |
| Ripal T. Gandhi | Member of Scientific Advisory Board | 2022 | - |
| David C. Madoff | Member of Scientific Advisory Board | 2022 | - |
| Francisco C. Carnevale | Member of Scientific Advisory Board | 2023 | - |
| Stavros Spiliopoulos | Member of Scientific Advisory Board | 2023 | - |
| Mark W. Little | Member of Scientific Advisory Board | 2023 | - |
| Gerry O'Sullivan | Member of Scientific Advisory Board | 2023 | - |
| Clare Bent | Member of Scientific Advisory Board | - | - |
| Irene Bargellini | Member of Scientific Advisory Board | - | - |
| David J. Wilson | Independent Director | 2024 | 58 |
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.